{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:41:27Z","timestamp":1789263687796,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.lana.2026.101439","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:54:59Z","timestamp":1774396499000},"page":"101439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trial"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2321-2295","authenticated-orcid":false,"given":"Oluwaseun","family":"Falade-Nwulia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2640-2211","authenticated-orcid":false,"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Barnaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-9005","authenticated-orcid":false,"given":"Sarah","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-2698","authenticated-orcid":false,"given":"Tarfa","family":"Verinumbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Wren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6827-9496","authenticated-orcid":false,"given":"Hamidreza","family":"Karimi-Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Cavacuiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"O'rear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Capraru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheree","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6352","authenticated-orcid":false,"given":"Mark","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.lana.2026.101439_bib1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global elimination of chronic hepatitis","volume":"380","author":"Thomas","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lana.2026.101439_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.lana.2026.101439_bib3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3109\/10826084.2016.1161054","article-title":"Clinicians' views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs","volume":"51","author":"Asher","year":"2016","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.lana.2026.101439_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2018.06.013","article-title":"\u2018Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs","volume":"190","author":"Skeer","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.lana.2026.101439_bib5","article-title":"Hepatitis C virus care cascade among people who inject drugs in Puerto Rico: minimal HCV treatment and substantial barriers to HCV care","volume":"8","author":"Aponte-Melendez","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"issue":"4","key":"10.1016\/j.lana.2026.101439_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302471","article-title":"Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing: systematic review and meta-analysis","volume":"19","author":"Kimball","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.lana.2026.101439_bib7","series-title":"Global health sector strategy on viral hepatitis, 2016-2021- the first of it's kind","year":"2016"},{"issue":"1","key":"10.1016\/j.lana.2026.101439_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12954-024-01131-6","article-title":"Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities","volume":"21","author":"Estadt","year":"2024","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.lana.2026.101439_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108525","article-title":"Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington","volume":"220","author":"Corcorran","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.lana.2026.101439_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.amepre.2021.04.013","article-title":"Cascade of Hepatitis C virus care among patients with substance use disorders","volume":"61","author":"Jiang","year":"2021","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.lana.2026.101439_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.lana.2026.101439_bib12","series-title":"Federal Guidelines for Opioid Treatment Programs","year":"2024"},{"key":"10.1016\/j.lana.2026.101439_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsat.2016.12.014","article-title":"Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program","volume":"75","author":"Butner","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.lana.2026.101439_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2019.01.021","article-title":"Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore","volume":"100","author":"Falade-Nwulia","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.lana.2026.101439_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"issue":"1\u20133","key":"10.1016\/j.lana.2026.101439_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/j.lana.2026.101439_bib17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lana.2026.101439_bib18","series-title":"The Hunger Vital Sign: a New Standard of Care for Preventive Health","author":"Goldman","year":"2014"},{"issue":"16","key":"10.1016\/j.lana.2026.101439_bib19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.lana.2026.101439_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implement Sci"},{"key":"10.1016\/j.lana.2026.101439_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-5908-9-7","article-title":"Organizational readiness for implementing change: a psychometric assessment of a new measure","volume":"9","author":"Shea","year":"2014","journal-title":"Implement Sci"},{"issue":"Suppl 5","key":"10.1016\/j.lana.2026.101439_bib22","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/infdis\/jiz686","article-title":"Hepatitis C Virus (HCV) care continuum outcomes and HCV community viral loads among patients in an opioid treatment program","volume":"222","author":"Jordan","year":"2020","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.lana.2026.101439_bib23","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S2468-1253(22)00275-8","article-title":"Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial","volume":"7","author":"Litwin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.lana.2026.101439_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa310","article-title":"Optimizing Hepatitis C Virus (HCV) treatment in a US Colocated HCV\/Opioid Agonist Therapy Program","volume":"7","author":"Habchi","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"16","key":"10.1016\/j.lana.2026.101439_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jama.2024.2452","article-title":"Integrated hepatitis C-Opioid use disorder care through facilitated telemedicine: a randomized trial","volume":"331","author":"Talal","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.lana.2026.101439_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciae520","article-title":"Peer-assisted telemedicine for hepatitis C in people who use drugs: a randomized controlled trial","volume":"80","author":"Seaman","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.lana.2026.101439_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38792","article-title":"Community-Based point-of-diagnosis hepatitis C treatment for marginalized populations: a nonrandomized controlled trial","volume":"6","author":"Morris","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.lana.2026.101439_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2019.11.012","article-title":"Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis","volume":"72","author":"Hajarizadeh","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.lana.2026.101439_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/cid\/ciad127","article-title":"Hepatitis C virus reinfection in a real-world cohort of homeless-experienced individuals in Boston","volume":"77","author":"Beiser","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:20:38Z","timestamp":1778836838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X26000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S2667193X26000694"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2026.101439","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2026.101439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101439"}}